Home » Healthcare » Pharmaceuticals » Anticoagulants Market

Anticoagulants Market By Drug Class (Novel Oral Anticoagulants (NOACs), Vitamin K Antagonists, Heparins & Low Molecular Weight Heparins (LMWH), Antiplatelet Agents, Thrombolytic Agents, Direct Thrombin Inhibitors), By Application (Atrial Fibrillation & Heart Attacks, Strokes, Deep Vein Thrombosis (DVT), Pulmonary Embolism) – Growth, Future Prospects, Competitive Analysis, 2018 – 2026

Summary
Table Of Content

Market Insights

The global anticoagulants market was valued at US$ 33,150.7 million in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% during the forecast period from 2018 to 2026. Anticoagulants are prescribed to patients who are at higher risk of clot formation in the blood and reduce the risk of serious conditions such as strokes and heart attacks. Anticoagulants are also given to treat pulmonary embolism, deep vein thrombosis (DVT), atrial fibrillation, and other cardiovascular diseases. Thus, the increasing prevalence of cardiovascular diseases, especially DVT, atrial fibrillation, and peripheral artery diseases, is a major growth factor assisting the market. The launch of several novel oral anticoagulants (NOACs) with improved properties in the last decade has completely changed the market scenario over the years. Warfarin, a vitamin K antagonist, was previously the most preferred anticoagulant because it was effective in inhibiting vitamin K recycling. However, the use of warfarin had certain limitations, such as continuous monitoring of the international normalized ratio (INR), i.e., drug levels and drug-food and drug-drug interactions, which acted as drawbacks for the market.

NOACs are also referred to as “non-vitamin K antagonist oral anticoagulants,” consisting of coagulation factors Xa inhibitors, factor IIa inhibitors, and direct thrombin inhibitors, which have a faster onset of action and fewer side effects compared to other drugs. The currently marketed NOACs include dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), edoxaban (Lixiana/Savaysa), and betrixaban (Bevyxxa). Xarelto by Bayer/Janssen Pharmaceuticals and Eliquis by Pfizer/Bristol-Myers Squibb is the most prescribed NOACs globally, owing to their impressive efficacy rates in the trials, lower side-effects such as uncontrollable bleeding, and the ability of the drugs to treat multiple indications, which give them an upper hand in the market. Bevyxxa by Portola Pharmaceuticals was the latest addition to the market, getting U.S. Food and Drug Administration (FDA) approval in June 2017 and launching in January 2018 for the prophylaxis of venous thromboembolism (VTE). This will further drive the market for anticoagulants.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Synopsis

Novel Oral Anticoagulants Will Drive the Anticoagulants Market During the Forecast Period

NOACs accounted for more than half of the total anticoagulants market in 2017. The segment is projected to exhibit the fastest growth rate during the forecast period as NOACs provide a higher advantage over vitamin K antagonists in terms of safety, lower side effects such as bleeding episodes, decreased need for continuous dosage monitoring, and availability of anticoagulant reversal agents. Higher prices of NOACs, as compared to other drug segments, also contribute to the growth of the market.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The anticoagulants market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on drug class, application, and geography.

The market is studied in order to understand the current dynamics and future trends in the global anticoagulants market. The study includes market size and forecasts for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rates (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in the anticoagulants market include Bayer AG, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Pfizer, Inc., Daiichi Sankyo Company Limited, and Portola Pharmaceuticals, Inc., among others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key questions are answered in this report.

How will the global anticoagulants market perform during the forecast period from 2018 to 2026?
What are the latest trends in the anticoagulants market and the most valuable opportunities for key players?
Who are the leading players in the global anticoagulants market?
Which is the leading and fastest-growing region in the global anticoagulants market?
What are the drivers and restraints governing the global market for anticoagulants?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Anticoagulants Market Portraiture
2.2. Global Anticoagulants Market, by Drug Class, 2017 (US$ Mn)
2.3. Global Anticoagulants Market, by Application, 2017 (US$ Mn)
2.4. Global Anticoagulants Market, by Geography, 2017 (US$ Mn)

Chapter 3. Anticoagulants: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Anticoagulants Market, by Key Players, 2017

Chapter 4. Global Anticoagulants Market, by Drug Class, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Novel Oral Anticoagulants (NOACs)
4.3. Vitamin K Antagonists
4.4. Heparins & Low Molecular Weight Heparins (LMWH)
4.5. Antiplatelet Agents
4.6. Thrombolytic Agents
4.7. Direct Thrombin Inhibitors
4.8. Pipeline Analysis (Forecast for Phase III drugs till 2026)

Chapter 5. Global Anticoagulants Market, by Application Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Atrial Fibrillation & Heart Attacks
5.3. Strokes
5.4. Deep Vein Thrombosis (DVT)
5.5. Pulmonary Embolism

Chapter 6. Global Anticoagulants Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Anticoagulants Market Analysis, 2016 – 2026
6.1.1. North America Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.1.2. North America Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.1.3. North America Anticoagulants Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Anticoagulants Market Analysis, 2016 – 2026
6.2.1. Europe Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.2.2. Europe Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. Europe Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Anticoagulants Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America Anticoagulants Market Analysis, 2016 – 2026
6.4.1. Latin America Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Anticoagulants Market, 2016 – 2026
6.5.1. Middle East & Africa Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa Anticoagulants Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Internation GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bayer AG
7.3. Johnson & Johnson, Inc.
7.4. Bristol-Myers Squibb Company
7.5. Pfizer, Inc.
7.6. Daiichi-Sankyo Company Limited
7.7. Portola Pharmaceuticals, Inc.
7.8. Sanofi S.A.
7.9. Aspen Holdings
7.10. GlaxoSmithKline Plc

List of Figures

FIG 1. Anticoagulants Market: Research Methodology
FIG 2. Anticoagulants: Market Segmentation
FIG 3. Global Anticoagulants Market, by Drug Class, 2017 (US$ Mn)
FIG 4. Global Anticoagulants Market, by Application Type, 2017 (US$ Mn)
FIG 5. Global Anticoagulants Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Anticoagulants Market, by Key Players, 2017
FIG 8. Global Novel Oral Anticoagulants (NOACs) Market, 2016-2026 (US$ Mn)
FIG 9. Global Vitamin K Antagonist Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 10. Global Heparins & Low Molecular Weight Heparins (LMWH) Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 11. Global Antiplatelet Agents Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 12. Global Thrombolytic Agents Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 13. Global Direct Thrombin Inhibitors Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 14. Global Anticoagulant Market for Atrial Fibrillation & Heart Attacks, 2016-2026(US$ Mn)
FIG 15. Global Anticoagulant Market for Strokes, 2016-2026(US$ Mn)
FIG 16. Global Anticoagulant Market for Deep Vein Thrombosis (DVT), 2016-2026(US$ Mn)
FIG 17. Global Anticoagulant Market for Pulmonary Embolism, 2016-2026(US$ Mn)
FIG 18. U.S. Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 19. Canada Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 20. U.K. Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 21. Germany Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Europe Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 23. China Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 24. Japan Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Asia Pacific Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 26. Brazil Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 27. Mexico Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Latin America Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 29. GCC Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 30. Rest of Middle East & Africa Anticoagulant Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Anticoagulant Market Portraiture
TABLE 2 Global Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 3 Global Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Anticoagulant Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 6 North America Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Anticoagulant Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Anticoagulant Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Internation GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Johnson & Johnson, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Daiichi-Sankyo Company Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Portola Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Aspen Holdings: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Anticoagulants Market?

The market for Anticoagulants Market is expected to reach US$ 33,150.7 Mn in 2026.

What is the Anticoagulants Market CAGR?

The Anticoagulants Market is expected to see significant CAGR growth over the coming years, at 6.6%.

What is the Forecast period considered for Anticoagulants Market?

The report is forecasted to 2018-2026.

What is the base year considered for Anticoagulants Market?

The base year of this report is 2017.

Who are the major players in this Market?

Boehringer Ingelheim Internation GmbH,Bayer AG,Johnson & Johnson, Inc.,Bristol-Myers Squibb Company,Pfizer Inc. are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –